Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Sub Total [Member]	Noncontrolling Interest [Member]	Total
Beginning balance, value at Dec. 31, 2020	$ 540	$ 102,366	$ (334,849)		$ (231,943)		$ (231,943)
Beginning balance, shares at Dec. 31, 2020	540,000
Stock based compensation	$ 1,855	382,149			384,004		384,004
Stock based compensation, shares	1,854,979
Stock issued for services	$ 1,653	240,347			242,000		242,000
Stock issued for services, shares	1,652,591
Stock issued as debt discount	$ 154	462,365			462,519		462,519
Stock issued as debt discount , shares	154,173
Effect of reverse merger transaction with Stemtech Corporation	$ 34,246	7,914,766	(5,674,006)	(410,750)	1,864,256	(616,208)	1,248,048
Effect of reverse merger transaction with Stemtech Corporation, shares	34,246,497
Foreign currency translation adjustment				(274,509)	(274,509)		(274,509)
Non-controlling interest						(24,997)	(24,997)
Net income			(6,237,957)		(6,237,957)		(6,237,957)
Ending balance, value at Sep. 30, 2021	$ 38,448	9,101,993	(12,246,812)	(685,259)	(3,791,630)	(641,205)	(4,432,835)
Ending balance, shares at Sep. 30, 2021	38,448,240
Beginning balance, value at Dec. 31, 2020	$ 540	102,366	(334,849)		(231,943)		(231,943)
Beginning balance, shares at Dec. 31, 2020	540,000
Ending balance, value at Dec. 31, 2021	$ 44,685	10,116,296	(13,086,318)	(430,255)	(3,355,592)	(649,854)	(4,005,446)
Ending balance, shares at Dec. 31, 2021	44,685,673
Beginning balance, value at Jun. 30, 2021	$ 540	153,542	(402,009)		(247,927)		(247,927)
Beginning balance, shares at Jun. 30, 2021	540,000
Stock based compensation	$ 1,001	257,999			259,000		259,000
Stock based compensation, shares	1,001,367
Stock issued as debt discount	$ 154	462,364			462,518		462,518
Stock issued as debt discount , shares	154,173
Effect of reverse merger transaction with Stemtech Corporation	$ 36,753	8,228,087	(6,535,413)	(207,267)	1,522,160	(630,943)	891,218
Effect of reverse merger transaction with Stemtech Corporation, shares	36,752,700
Foreign currency translation adjustment				(477,992)	(477,992)		(477,992)
Non-controlling interest						(10,262)	(10,262)
Net income			(5,309,390)		(5,309,390)		(5,309,390)
Ending balance, value at Sep. 30, 2021	$ 38,448	9,101,993	(12,246,812)	(685,259)	(3,791,630)	(641,205)	(4,432,835)
Ending balance, shares at Sep. 30, 2021	38,448,240
Beginning balance, value at Dec. 31, 2021	$ 44,685	10,116,296	(13,086,318)	(430,255)	(3,355,592)	(649,854)	(4,005,446)
Beginning balance, shares at Dec. 31, 2021	44,685,673
Stock based compensation		328,388			328,388		328,388
Stock issued for services	$ 986	2,835,125			2,836,111		2,836,111
Stock issued for services, shares	984,344
Stock issued for loan extension	$ 946	3,620,828			3,621,774		3,621,774
Stock issued for loan extension, shares	945,512
Conversion of convertible notes and accrued interest to common stock	$ 1,935	636,065			638,000		638,000
Conversion of convertible notes and accrued interest to common stock , shares	1,935,330
Shares issued as debt issuance cost	$ 74	199,926			200,000		200,000
Shares issued as debt issuance cost , shares	74,488
Foreign currency translation adjustment				(243,667)	(243,667)		(243,667)
Non-controlling interest						(65,034)	(65,034)
Net income			(8,026,062)		(8,026,062)		(8,026,062)
Ending balance, value at Sep. 30, 2022	$ 48,626	17,736,628	(21,112,380)	(673,922)	(4,001,048)	(714,888)	(4,715,936)
Ending balance, shares at Sep. 30, 2022	48,625,347
Beginning balance, value at Jun. 30, 2022	$ 44,795	10,663,909	(38,529,297)	(267,548)	(28,088,141)	(684,181)	(28,772,322)
Beginning balance, shares at Jun. 30, 2022	44,795,673
Stock based compensation		110,665			110,665		110,665
Stock issued for services	$ 976	2,805,135			2,806,111		2,806,111
Stock issued for services, shares	974,344
Stock issued for loan extension	$ 846	3,320,928			3,321,774		3,321,774
Stock issued for loan extension, shares	845,512
Conversion of convertible notes and accrued interest to common stock	$ 1,935	636,065			638,000		638,000
Conversion of convertible notes and accrued interest to common stock , shares	1,935,330
Shares issued as debt issuance cost	$ 74	199,926			200,000		200,000
Shares issued as debt issuance cost , shares	74,488
Foreign currency translation adjustment				(406,374)	(406,374)		(406,374)
Non-controlling interest						(30,707)	(30,707)
Net income			17,416,917		17,416,917		17,416,917
Ending balance, value at Sep. 30, 2022	$ 48,626	$ 17,736,628	$ (21,112,380)	$ (673,922)	$ (4,001,048)	$ (714,888)	$ (4,715,936)
Ending balance, shares at Sep. 30, 2022	48,625,347